FDA Approves Boehringer NADA for Canine Osteoarthritis
12/10/2003
Federal Register Final rule: FDA is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Boehringer Ingelheim Vetmedica, Inc. that provides for use of meloxicam injectable solution in dogs for the control of pain and inflammation associated with osteoarthritis. To view this final rule, click here.
